File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Thromboembolism prophylaxis during laparoscopic cholecystectomy

TitleThromboembolism prophylaxis during laparoscopic cholecystectomy
Authors
Issue Date1997
PublisherJohn Wiley & Sons Ltd. The Journal's web site is located at http://www.bjs.co.uk
Citation
British Journal Of Surgery, 1997, v. 84 n. 7, p. 962-964 How to Cite?
AbstractBackground: The aim of this study was to determine current UK practice with regard to thromboembolism prophylaxis during laparoscopic cholecystectomy. Methods: Postal questionnaires were sent to 800 members of the Association of Surgeons; replies were received from 551 surgeons (69 per cent) of whom 417 practised laparoscopic cholecystectomy. Results: Heparin was prescribed to all patients by 74 per cent, and selectively by 20 per cent, of respondents. Surgeons who performed fewer than ten laparoscopic cholecystectomies per annum were significantly less likely to use heparin (P < 0.001) and more likely to believe that heparin produces significant adverse bleeding (P < 0.01). Thirty per cent of respondents used low molecular weight heparin. Stockings to deter thromboembolism were used by 74 per cent, and pneumatic compression by 37 per cent. Indications for heparin varied considerably and were not influenced by Thromboembolic Risk Factors (THRIFT) guidelines. Only 20 per cent of respondents considered that thromboembolism was a problem; 91 per cent reported that they had never experienced a thromboembolic complication following laparoscopic cholecystectomy. Conclusion: The rate of thromboembolism after laparoscopic cholecystectomy is unknown but most surgeons believe the risk is very low. Surgeons' attitudes towards thromboembolism prophylaxis are variable, but most experienced surgeons use low-dose heparin.
Persistent Identifierhttp://hdl.handle.net/10722/146817
ISSN
2023 Impact Factor: 8.6
2023 SCImago Journal Rankings: 2.148
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorBradbury, AWen_HK
dc.contributor.authorChan, YCen_HK
dc.contributor.authorDarzi, Aen_HK
dc.contributor.authorStansby, Gen_HK
dc.date.accessioned2012-05-22T08:35:54Z-
dc.date.available2012-05-22T08:35:54Z-
dc.date.issued1997en_HK
dc.identifier.citationBritish Journal Of Surgery, 1997, v. 84 n. 7, p. 962-964en_HK
dc.identifier.issn0007-1323en_HK
dc.identifier.urihttp://hdl.handle.net/10722/146817-
dc.description.abstractBackground: The aim of this study was to determine current UK practice with regard to thromboembolism prophylaxis during laparoscopic cholecystectomy. Methods: Postal questionnaires were sent to 800 members of the Association of Surgeons; replies were received from 551 surgeons (69 per cent) of whom 417 practised laparoscopic cholecystectomy. Results: Heparin was prescribed to all patients by 74 per cent, and selectively by 20 per cent, of respondents. Surgeons who performed fewer than ten laparoscopic cholecystectomies per annum were significantly less likely to use heparin (P < 0.001) and more likely to believe that heparin produces significant adverse bleeding (P < 0.01). Thirty per cent of respondents used low molecular weight heparin. Stockings to deter thromboembolism were used by 74 per cent, and pneumatic compression by 37 per cent. Indications for heparin varied considerably and were not influenced by Thromboembolic Risk Factors (THRIFT) guidelines. Only 20 per cent of respondents considered that thromboembolism was a problem; 91 per cent reported that they had never experienced a thromboembolic complication following laparoscopic cholecystectomy. Conclusion: The rate of thromboembolism after laparoscopic cholecystectomy is unknown but most surgeons believe the risk is very low. Surgeons' attitudes towards thromboembolism prophylaxis are variable, but most experienced surgeons use low-dose heparin.en_HK
dc.languageeng-
dc.publisherJohn Wiley & Sons Ltd. The Journal's web site is located at http://www.bjs.co.uken_HK
dc.relation.ispartofBritish Journal of Surgeryen_HK
dc.rightsBritish Journal of Surgery. Copyright © John Wiley & Sons Ltd.-
dc.subject.meshAttitude of Health Personnel-
dc.subject.meshCholecystectomy, Laparoscopic - adverse effects-
dc.subject.meshHeparin - therapeutic use-
dc.subject.meshHeparin, Low-Molecular-Weight - therapeutic use-
dc.subject.meshThromboembolism - prevention and control-
dc.titleThromboembolism prophylaxis during laparoscopic cholecystectomyen_HK
dc.typeArticleen_HK
dc.identifier.emailChan, YC: ycchan88@hkucc.hku.hken_HK
dc.identifier.authorityChan, YC=rp00530en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1002/bjs.1800840715en_HK
dc.identifier.pmid9240136-
dc.identifier.scopuseid_2-s2.0-0030804919en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0030804919&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume84en_HK
dc.identifier.issue7en_HK
dc.identifier.spage962en_HK
dc.identifier.epage964en_HK
dc.identifier.isiWOS:A1997XJ49400012-
dc.publisher.placeUnited Kingdomen_HK
dc.identifier.scopusauthoridBradbury, AW=7102122383en_HK
dc.identifier.scopusauthoridChan, YC=27170769400en_HK
dc.identifier.scopusauthoridDarzi, A=14633357600en_HK
dc.identifier.scopusauthoridStansby, G=7004963829en_HK
dc.identifier.issnl0007-1323-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats